Relation of aldosterone “escape” despite angiotensin-converting enzyme inhibitor administration to impaired exercise capacity in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy-Reference-Cited by-同舟云学术

Relation of aldosterone “escape” despite angiotensin-converting enzyme inhibitor administration to impaired exercise capacity in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

Published:2002-02 Issue:4 Volume:89 Page:403-407
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Cicoira Mariantonietta,Zanolla Luisa,Franceschini Lorenzo,Rossi Andrea,Golia Giorgio,Zeni Prisca,Caruso Beatrice,Zardini Piero

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure;Roig;Eur Heart J,2000

2. The chimase-angiotensin system in humans;Husain;J Hypertens,1993

3. “Escape” of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor;Pitt;Cardiovasc Drugs Ther,1995

4. Heart Failure;Weber,1993

5. Neurohormonal reactivation in heart failure patients on chronic ACE inhibitor therapy;Lee;Eur J Heart Fail,1999

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Narrative Review of the Diagnosis and Treatment of Sarcopenia and Malnutrition in Patients with Heart Failure;Nutrients;2024-08-15

2. Mineralocorticoid receptor antagonists with sodium–glucose co-transporter-2 inhibitors in heart failure: a meta-analysis;European Heart Journal;2023-08-22

3. Mechanism of angiotensin-converting enzyme inhibitors in the treatment of dilated cardiomyopathy based on a protein interaction network and molecular docking;Cardiovascular Diagnosis and Therapy;2023-06

4. Cardiac care of children with dystrophinopathy and females carrying DMD-gene variations;Open Heart;2022-10

5. Modifying chronic kidney disease progression with the mineralocorticoid receptor antagonist finerenone in patients with type 2 diabetes;Diabetes, Obesity and Metabolism;2022-04-18